Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-205,000
Closed -$56.4M 116
2025
Q4
$56.4M Buy
205,000
+42,200
+26% +$11.8M 1.15% 25
2025
Q3
$46.9M Buy
+162,800
New +$48.2M 1.1% 31
2023
Q4
Sell
-231,500
Closed -$66.2M 119
2023
Q3
$66.2M Buy
231,500
+70,500
+44% +$20.1M 1.41% 24
2023
Q2
$45.2M Buy
+161,000
New +$41.9M 0.82% 45
2020
Q3
Sell
-439,700
Closed -$82.5M 148
2020
Q2
$82.5M Hold
439,700
1.16% 28
2020
Q1
$77.9M Sell
439,700
-50,000
-10% -$9.7M 1.31% 29
2019
Q4
$100M Buy
489,700
+198,100
+68% +$36.3M 1.43% 21
2019
Q3
$44.3M Buy
291,600
+39,000
+15% +$6.35M 0.84% 39
2019
Q2
$39.8M Hold
252,600
0.62% 47
2019
Q1
$40.6M Sell
252,600
-230,100
-48% -$42M 0.63% 46
2018
Q4
$91.7M Sell
482,700
-151,200
-24% -$31.5M 1.7% 15
2018
Q3
$132M Buy
633,900
+419,100
+195% +$77.7M 1.59% 18
2018
Q2
$36.5M Buy
214,800
+22,500
+12% +$3.89M 0.44% 62
2018
Q1
$32.3M Sell
192,300
-777,000
-80% -$151M 0.4% 65
2017
Q4
$197M Sell
969,300
-296,800
-23% -$59.1M 2.49% 11
2017
Q3
$237M Buy
1,266,100
+44,000
+4% +$7.83M 2.26% 10
2017
Q2
$205M Buy
+1,222,100
New +$196M 2.14% 15
2016
Q4
Sell
-325,700
Closed -$42.4M 135
2016
Q3
$42.4M Sell
325,700
-3,900
-1% -$509K 0.48% 58
2016
Q2
$42.2M Sell
329,600
-5,900
-2% -$779K 0.44% 53
2016
Q1
$46M Buy
335,500
+53,500
+19% +$7.35M 0.48% 50
2015
Q4
$41.3M Buy
+282,000
New +$38.8M 0.37% 56
2013
Q4
Sell
-438,000
Closed -$33.7M 125
2013
Q3
$33.7M Buy
438,000
+11,000
+3% +$859K 0.6% 41
2013
Q2
$31M Buy
+427,000
New +$28.8M 0.66% 35

Other funds holding CI

OrbiMed's CI Position: Q1 2026 in Review

OrbiMed sold out of Cigna (CI) in Q1 2026, closing a stake of 205,000 shares — an estimated $56.4M sold.

OrbiMed first reported a position in CI in Q2 2013 and held it in 23 quarters. The position peaked at $237M in Q3 2017. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • OrbiMed reported no remaining Cigna position as of Q1 2026 after selling out during the quarter.
  • OrbiMed sold 205,000 Cigna shares in Q1 2026, an estimated $56.4M.
  • OrbiMed first reported a position in Cigna in Q2 2013 and held it in 23 quarters.
  • OrbiMed's Cigna position peaked at $237M in Q3 2017.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on OrbiMed's 13F filing for Q1 2026, filed 15 May 2026.